Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Bark

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The Medical Clinics of North America|April 4, 2025
Severe TuberculosisGrace Muzanyi, Charles M Bark
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
TB, or not TB, the Choice Is OursCyndee Miranda, Charles M Bark
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 9, 2014
Differences in EBA in the first two days of standard anti-tuberculosis treatment in different geographic regionsCharles M Bark, Phineas Gitta, John L Johnson
Annual Review of Medicine|November 20, 2023
More Tailored Approaches to Tuberculosis Treatment and PreventionCharles M Bark, W Henry Boom, Jennifer J Furin
Infectious Disease Clinics of North America|May 22, 2016
Drug-Resistant Tuberculosis: Challenges and ProgressSebastian G Kurz, Jennifer J Furin, Charles M Bark
Journal of Clinical Microbiology|November 26, 2011
Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapyCharles M Bark, Bonnie A Thiel, John L Johnson
Infectious Disease Clinics of North America|October 4, 2020
Drug-Resistant Tuberculosis: A Glance at Progress and Global ChallengesKhalid M Dousa, Sebastian G Kurz, Charles M Bark, et al.
Journal of Clinical Microbiology|October 28, 2011
Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancerCharles M Bark, Rana S Traboulsi, Kord Honda, et al.
Diagnostic Microbiology and Infectious Disease|August 5, 2015
Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnosesSam Ogwang, Paul Mubiri, Charles M Bark, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxisSam Ogwang, Caryn E Good, Brenda Okware, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The Medical Clinics of North America|April 4, 2025
Severe TuberculosisGrace Muzanyi, Charles M Bark
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
TB, or not TB, the Choice Is OursCyndee Miranda, Charles M Bark
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 9, 2014
Differences in EBA in the first two days of standard anti-tuberculosis treatment in different geographic regionsCharles M Bark, Phineas Gitta, John L Johnson
Annual Review of Medicine|November 20, 2023
More Tailored Approaches to Tuberculosis Treatment and PreventionCharles M Bark, W Henry Boom, Jennifer J Furin
Infectious Disease Clinics of North America|May 22, 2016
Drug-Resistant Tuberculosis: Challenges and ProgressSebastian G Kurz, Jennifer J Furin, Charles M Bark
Journal of Clinical Microbiology|November 26, 2011
Pretreatment time to detection of Mycobacterium tuberculosis in liquid culture is associated with relapse after therapyCharles M Bark, Bonnie A Thiel, John L Johnson
Infectious Disease Clinics of North America|October 4, 2020
Drug-Resistant Tuberculosis: A Glance at Progress and Global ChallengesKhalid M Dousa, Sebastian G Kurz, Charles M Bark, et al.
Journal of Clinical Microbiology|October 28, 2011
Disseminated Mycobacterium chelonae infection in a patient receiving an epidermal growth factor receptor inhibitor for advanced head and neck cancerCharles M Bark, Rana S Traboulsi, Kord Honda, et al.
Diagnostic Microbiology and Infectious Disease|August 5, 2015
Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnosesSam Ogwang, Paul Mubiri, Charles M Bark, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2015
Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxisSam Ogwang, Caryn E Good, Brenda Okware, et al.
Pageof 2